Abstract
Background: The detection of molecular targets for flavonoids in cell signalling has opened new perspectives for their application in medicine. Both tangeretin, a citrus methoxyflavone, and xanthohumol, the main prenylated chalcone present in hops (Humulus lupulus L.), act on the mitogen-activated protein kinase pathway and await further investigation for administration in vivo. Materials and Methods: A safety study was designed in laboratory mice orally administered concentrates of purified tangeretin (1 × 10-4 M) or xanthohumol (5 × 10-4 M) at libitum for 4 weeks. Blood samples were collected for the analysis of a variety of haematological and biochemical parameters. Results: A reduction of the circulating lymphocyte number was noticed for tangeretin, while all other parameters were unaffected by treatment with either tangeretin or xanthohumol. The parameters encompassed an integrity check of the following tissues and organs: bone marrow, liver, exocrine pancreas, kidneys, muscles, thyroid, ovaries and surrenal cortex. Furthermore, no differences were noted in the metabolism of proteins, lipids, carbohydrates and uric acid, as well as in ion concentrations. Conclusion: All data indicate that oral administration of tangeretin or xanthohumol to laboratory mice does not affect major organ functions and opens the gate for further safety studies in humans.
Footnotes
- Received September 10, 2004.
- Accepted December 16, 2004.
- Copyright © 2005 The Author(s). Published by the International Institute of Anticancer Research.
